VEnvirotech transforms organic waste into bioplastics

After a year of testing out environmental technologies for a private company, co-founder Patricia Ayma developed a process for bioplastic production using bacteria. The system turns organic matter, such as food waste, into a product that can be used as a biodegradable alternative to single-use plastics. “I realized that it was a simple technology for […]

Luna is a new kind of space company helping biotech find its footing in microgravity

Toronto-based startup Luna Design and Innovation is a prime example of the kind of space company that is increasingly starting up to take advantage of the changing economics of the larger industry. Founded by Andrea Yip, who is also Luna’s CEO, the bootstrapped venture is looking to blaze a trail for biotechnology companies who stand […]

Newly launched pet health startup Gallant wants you to bank your dog’s stem cells for $990

With $11 million in funding and a mission to open up the doors of regenerative therapies to dogs across the nation, the Los Angeles-based startup Gallant is now opening its doors for the first time. The company was founded by DogVacay founder and chief executive Aaron Hirschhorn after seeing his own pet’s struggle with debilitating […]

UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon

Cambridge, UK-based biotech startup Mogrify, which is working on systematizing the development of novel cell therapies in areas such as regenerative medicine, has closed an initial $16 million Series A. The raise from investors Ahren Innovation Capital, Parkwalk and 24Haymarket follows a $4M seed in February — taking its total raised to date to $20M. Put simply, Mogrify’s approach […]

Boston gets a new biotech accelerator with the launch of Petri

As biotechnology becomes more central to new innovations in healthcare, material science and manufacturing, one of the nation’s research hubs is getting a new accelerator called Petri to launch companies focused on the commercialization of new technologies. Backed by the Boston-based venture capital firm Pillar, Petri has a three-year $15 million commitment to back companies […]

Terramera raises $45 million for its technology to reduce the use of chemicals in agriculture

Terramera, a Canadian company selling bio-pesticides and seed treatments to reduce the use of chemicals in agriculture, has raised $45 million in its latest round of financing. The round was led by strategic investor Ospraie Ag Science and the company’s previous backer, Seed2Growth Ventures. Led by Carl Casale, a former Monsanto executive, Ospraie Ag Science […]

Through a new partnership and $72 million in funding, LanzaTech expands its carbon capture tech

For nearly 15 years LanzaTech has been developing a carbon capture technology that can turn waste streams into ethanol that can be used for chemicals and fuel. Now, with $72 million in fresh funding at a nearly $1 billion valuation and a newly inked partnership with biotechnology giant Novo Holdings, the company is looking to […]

Where are all the biotech startups raising?

Where are all the biotechnology companies raising these days? We crunched some numbers to arrive at an answer. Using funding rounds data from Crunchbase, we plotted the count of venture capital funding rounds raised by companies in the fairly expansive biotechnology category in Crunchbase. Click the chart below and you can hover over individual data […]

DNA Script picks up $38.5 million to make DNA production faster and simpler

DNA Script has raised $38.5 million in new financing to commercialize a process that it claims is the first big leap forward in manufacturing genetic material. The revolution in synthetic biology that’s reshaping industries from medicine to agriculture rests on three, equally important pillars. They include: analytics — the ability to map the genome and […]

Driving down the cost of preserving genetic material, Acorn Biolabs raises $3.3 million

Acorn Biolabs wants consumers to pay them to store genetic material in a bet that the increasing advances in targeted genetic therapies will yield better healthcare results down the line. The company’s pitch is to “Save young cells today, live a longer, better, tomorrow.” It’s a gamble on the frontiers of healthcare technology that has managed […]